Negative or purifying selection is selection acting against new deleterious mutations. A consequence of negative selection is the removal of new deleterious genetic variants from the population, resulting in evolutionary sequence conservation. The intensity of negative selection, or "evolutionary constraint," can vary across the genome according to functional properties encoded by the respective loci ([@mst098-B10]; [@mst098-B44]; [@mst098-B43]). Repetitive intergenic sequences far from coding regions likely evolve relatively freely because evolutionary changes here will not affect the fitness of the organism. By contrast, evolutionary changes in protein-coding genes, especially those involved in essential cellular functions, in development, or in the central nervous system, can readily impact organismal function and fitness; the evolution of such genes may be highly constrained. Such constraint can be detected in actual genomic data, both among and within species. For example, genes expressed across multiple tissues and/or functioning in the neural system have low nonsynonymous to synonymous mutation rates among mammals (d*N/*d*S*) ([@mst098-B25]; [@mst098-B13]; [@mst098-B32]; [@mst098-B33]). Within humans, genic regions contain fewer polymorphism than intergenic regions, and nonsynonymous single nucleotide polymorphisms (nsSNPs) are maintained at lower frequencies than synonymous SNPs (sSNPs) ([@mst098-B6]; [@mst098-B44]).

Levels of evolutionary constraint, reflected in genetic sequence conservation, are generally correlated across related species---the same genes and functions show high or low constraint in hominids and rodents ([@mst098-B35]; [@mst098-B32]). Still, exceptions can arise through multiple mechanisms ([@mst098-B14]). First, the strength of natural selection is expected to be a function of effective population size, such that lineages with relatively small population sizes may experience weaker negative selection throughout the genome. In populations experiencing reductions in population size, slightly deleterious mutations which were originally not tolerated may drift to high frequency, and even become fixed ([@mst098-B36]). For example, humans and chimpanzees have higher genome-wide d*N/*d*S* levels compared with rodents, possibly due to the smaller effective population size in hominids allowing fixation of slightly deleterious alleles ([@mst098-B53]; [@mst098-B27]; [@mst098-B35]; [@mst098-B32]).

A decrease in negative selection pressure caused by reduced effective population size should affect a large number of genes across the genome. In turn, changes in a species' environment or in its genome can relax negative selection on individual genes or classes of genes. One such change is gene duplication, which could reduce negative selection on the duplicated copies ([@mst098-B34]; [@mst098-B23]). Changes in environment and subsistence mode can similarly cause relaxation of selection in specific genes. The best-known example in humans is olfactory receptors ([@mst098-B42]). This vast gene family appears under relaxed selection in New World monkeys, Old World monkeys, and hominoids, as observed in the high rates of pseudogenization and deletion of member genes; possibly due to a transition from nocturnal to diurnal activity in these lineages ([@mst098-B16], [@mst098-B17]; [@mst098-B18]; [@mst098-B22]; [@mst098-B30]) (positive selection on olfactory genes in humans has also been reported \[[@mst098-B52]\]). A recent study on relaxation of constraint in the human genome similarly found a high frequency of potentially damaging nonsynonymous polymorphism among olfactory receptors ([@mst098-B37]). Interestingly, mutations causing color blindness are also common in humans, but not in chimpanzees, for reasons yet unclear ([@mst098-B48]).

Studying human-specific changes at evolutionarily conserved sites could provide insight into how the human species has diverged from its relatives. A number of studies have searched for conserved regions that have accumulated a high number of fixed substitutions on the human lineage; these are likely examples of adaptive evolution ([@mst098-B38]; [@mst098-B39]; [@mst098-B40]). Other studies have identified nonconserved regions under purifying selection in humans ([@mst098-B51]), found relaxed negative selection in recently evolved primate genes ([@mst098-B5]), and shown relaxed constraints among human and nonhuman primate olfactory genes using comparative genomic data ([@mst098-B16]; [@mst098-B18]) and using human polymorphism data ([@mst098-B37]).

Here, we address the question of human-specific relaxation of negative selection at coding sites, combining genome resequencing data from humans, exome sequencing data from chimpanzees, and comparative genomic data.

Results and Discussion
======================

We tested for human-specific relaxation of constraint among groups of functionally related genes using three criteria: 1) genes in a group should have low levels of mammalian protein sequence divergence but relatively high human nonsynonymous diversity, 2) that the group should have higher human nonsynonymous diversity levels than the genome average, 3) that the group should have low levels of chimpanzee nonsynonymous diversity relative to human diversity ([fig. 1](#mst098-F1){ref-type="fig"}*A*). F[ig]{.smallcaps}. 1.(*A*) Representation depicting the tests for human-specific relaxed selection. Genes in a gene set are ranked according to functional human diversity (nsMAF), mammalian divergence (d*N/*d*S*), or chimpanzee diversity (nsMAF). The ranks are compared using a Wilcoxon signed rank test ([supplementary material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). (*B*) Median human nsMAF and mouse--rhesus macaque d*N/*d*S* values among 181 KEGG pathways, each containing minimum five genes. Each dot represents one KEGG gene set. Groups that have significantly higher human diversity ranks relative to mammalian divergence ranks (as in *A*, Wilcoxon signed rank test), and also have significantly higher human diversity in member genes compared with the genome average (Wilcoxon rank sum test), are indicated in red. (*C*) Genes (*n* = 12,405) were ranked according to their relative mouse--rhesus macaque d*N/*d*S* (right) or human nsMAF (left) values, with higher ranks indicating weaker negative selection. Each line represents a gene and connects its d*N/*d*S* and nsMAF-based ranks. The red lines show proteasome and green lines show selenoamino acid metabolism genes. The two groups were chosen as examples representing significant shifts or no shifts toward human--specific relaxation, respectively. (*D*) nsMAF values at common proteasome nsSNPs (world-wide MAF \> 0.05) in Africans and non-Africans. nsMAF in the non-African sample is higher, but not significantly (Wilcoxon signed rank test *P* = 0.2). (*E*) Median human nsMAF and chimpanzee nsMAF values among 182 KEGG pathways with minimum give genes, shown as in (*A*).

We first catalogued over 64,000 nonsynonymous and over 54,000 synonymous SNPs ascertained in 54 unrelated individuals of diverse ancestry in the Complete Genomics genome-wide high coverage resequencing data set ([@mst098-B12]) ([supplementary material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). The nonsynonymous minor allele frequency (nsMAF) distribution was highly skewed toward lower values relative to the synonymous minor allele frequency (sMAF) distribution ([supplementary fig. S1*A*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online), consistent with the role of negative selection preventing nonsynonymous mutations from reaching high frequency ([@mst098-B6]). Median nsMAF values, calculated per gene, showed modest but significant correlation with d*N/*d*S* values per orthologous gene, calculated between mouse and macaque, or dog and elephant (*ρ* ∼ 0.20, one-sided Spearman correlation test *P* \< 10^−80^, *n* \> 10,000 genes) ([supplementary fig. S1*B*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) and [*C*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). This correlation likely reflects similar levels of negative selection between and within species.

Using forward population genetic simulation ([@mst098-B19]), we then tested whether 20 loci evolving under purely neutral regimes could be identified among 1,000 loci evolving under negative and positive selection ([supplementary material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). There was modest (\>40%) power to distinguish between neutral and negative selection, which increased to more than 60% using 40 loci ([supplementary fig. S2](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). We also found that MAF is a somewhat more robust measure for identifying neutrally evolving loci than derived allele frequency (DAF) if the alternative hypothesis is a mixture of positive and negative selection, as DAF is more strongly affected by positive selection ([supplementary fig. S2](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). These results suggest that median nsMAF is a useful statistic for investigating hypotheses regarding relaxation of constraints in the human genome.

Human nsMAF and mammalian d*N/*d*S* values showed correlation when summarized in 181 KEGG pathways ([@mst098-B21]) ([fig. 1](#mst098-F1){ref-type="fig"}*B*). Only a few functional groups stood out, with higher median nsMAF, despite low median d*N/*d*S*. These included not only various metabolic pathways, such as propanoate metabolism and glycosaminoglycan degradation, but also olfactory transduction, and the proteasome ([supplementary table S1](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). We then tested whether genes in a functional group have the same median ranks with respect to d*N/*d*S*, relative to their ranks with respect to nsMAF ([fig. 1](#mst098-F1){ref-type="fig"}*A* and *C*) (Wilcoxon signed rank test). We further tested whether a gene set has the same median rank of nsMAF values compared with other genes (Wilcoxon rank sum test). Only two KEGG groups showed higher than expected polymorphism in both tests: olfactory transduction and the proteasome (Benjamini-Hochberg corrected *P* \< 0.05, [supplementary table S1](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). Among the 373 genes in the olfactory transduction pathway, 323 contained at least one nsSNP (median nsMAF = 0.029). Among the 44 genes annotated within the proteasome category, 18 contained nsSNPs (median nsMAF = 0.044), 12 of these with modest to high frequency (\>5%) alleles among both African and non-African individuals ([fig. 1](#mst098-F1){ref-type="fig"}*D*). A randomization test across genes confirmed that nsMAF values in both groups are significantly skewed compared with other genes with nsSNPs (*P* \< 0.0001; note that the olfactory receptors are found in clusters, which is ignored in this test; proteasome genes, however, tend to reside on different chromosomes and are not clustered).

We then asked whether these putative shifts in negative selection pressure can also be observed in our closest living relatives, the chimpanzees, or whether they might be human specific. For this, we used a published exome resequencing data set containing close to 25,000 nonsynonymous and 32,000 synonymous SNPs ascertained in 12 central chimpanzees, *Pan troglodytes troglodytes* ([@mst098-B20]) ([supplementary material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). Examining KEGG pathways for a difference in human nsMAF ranks relative to chimpanzee nsMAF ranks, we found olfactory transduction and proteasome genes were among the top eight pathways exhibiting the most significant differences across 181 pathways (nominal Wilcoxon signed rank test *P* \< 0.05; although the proteasome gene set was not significant after multiple testing correction) ([fig. 1](#mst098-F1){ref-type="fig"}*E*; [supplementary table S1](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). By randomizing genes across KEGG groups and repeating the three tests (i.e., comparing human nsMAF in each KEGG group with the genome average, comparing nsMAF per group with d*N/*d*S,* and with chimpanzee nsMAF) 10,000 times, we determined that finding two groups with significant results in all tests was unlikely (*P* = 0.0015).

We repeated the analysis using the mean instead of median nsMAF per gene, as well as the proportion of common (\>5% MAF) nonsynonymous SNPs per gene. Again, olfactory transduction and proteasome groups had significant results in all three tests ([supplementary fig. S3*A--D*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) and [table S2](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). Next, we used the phase I version of the 1000 genomes data set, which contains a substantially larger set of individuals, although representing a smaller subset of worldwide human genetic variation ([@mst098-B1]). Because our analyses focus on common polymorphism, we only included SNPs at MAF more than 0.005 in this data set (∼54,000 nsSNPs). Olfactory transduction and proteasome genes again showed a trend of higher human polymorphism relative to mammalian divergence or to chimpanzee polymorphism (although this trend was not statistically significant using mean nsMAF) ([supplementary fig. S3*F--H*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online).

A closer examination of the chimpanzee polymorphism at olfactory transduction-related genes revealed that these genes also had higher-than-average nsMAF in chimpanzees ([fig. 2](#mst098-F2){ref-type="fig"}*A* and *B*). Relaxed negative selection on olfactory genes may therefore be a shared trend between humans and chimpanzees, albeit more pronounced in humans. This is consistent with the tendency of the olfactory receptor family toward pseudogenization in primates, likely reflecting decreased reliance on olfactory perception in this lineage ([@mst098-B16], [@mst098-B17]; [@mst098-B22]; [@mst098-B30]; [@mst098-B37]), as well as positive or balancing selection ([@mst098-B52]). F[ig]{.smallcaps}. 2.Distribution of median MAF for nsSNPs and sSNPs in human (left panels) and chimpanzee (right panels), across genes in three KEGG pathways: olfactory transduction (*n* = 323), proteasome (*n* = 18), and Wnt signaling (*n* = 87), compared with the all genes annotated in KEGG and with nsSNPs in human and chimpanzee data sets (*n* = 3,741). Wnt signaling was chosen here as an example category that is expected to be under strong negative selection in both human and chimpanzee. The left and right *y* axes show the percentage of genes falling in a MAF quantile across all genes or genes in a KEGG pathway, respectively. We use the same subset of genes with SNPs detected in both human and chimpanzee. Note that the chimpanzee site frequency spectrum is less skewed to the left than that of human, due to the fact that we use 12 chimpanzee and 54 human subjects. The asterisks show significance measured in a two-sided Wilcoxon rank sum test. °*P* \< 0.10; \*\**P* \< 0.01; \*\*\**P* \< 0.001.

In contrast, there is no indication of higher nsMAF values among chimpanzee proteasome genes ([fig. 2](#mst098-F2){ref-type="fig"}*D*), despite what was observed in humans ([fig. 2](#mst098-F2){ref-type="fig"}*C*). Our chimpanzee data are limited to only 12 individuals and therefore the variability in chimpanzee MAF estimates are high. Nevertheless, we find no evidence of relaxation of selection in chimpanzees. For example, the nsMAF spectrum in chimpanzee Wnt signaling pathway genes, which regulate major developmental processes and are thus expected to remain under strong negative selection in both humans and chimpanzees, is comparable with the distribution of nsMAF in chimpanzee proteasome genes ([fig. 2](#mst098-F2){ref-type="fig"}*D* and *F*). This provides another line of evidence that the proteasome genes are likely evolving under negative selection in chimpanzees.

Indeed, like the spliceosome, the proteasome is a major component of eukaryotic cells. This is the key machinery for degrading proteins marked by ubiquitin, which can be damaged or misfolded proteins, signaling proteins involved in cell cycle and apoptosis, or antigens ([@mst098-B11]; [@mst098-B41]; [@mst098-B7]; see [@mst098-B8] and [@mst098-B46] for reviews). The main structure contains a 20S catalytic core, consisting of two sets of seven alpha and seven beta subunits, and two sets of 19S regulatory particles, containing 18 distinct subunits each ([fig. 3](#mst098-F3){ref-type="fig"}*A* and *B*). Each subunit is coded by one gene. Combined with additional peptides, these structures can further give rise to the immunoproteasome or the thymoproteasome ([@mst098-B46]). Notably, among proteasome subunits, those with nsSNPs have slightly higher d*N/*d*S* levels relative to those without nsSNPs ([supplementary fig. S4](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). Still, all proteasome gene sets have significantly lower mammalian d*N/*d*S* values compared with the rest of the genome, indicating strong conservation (Wilcoxon rank sum test *P* \< 0.05). F[ig]{.smallcaps}. 3.(*A*) Schematic representation of the proteasome 20S core and 19S regulatory particles based on ([@mst098-B46]). Peptides are colored with respect to their polymorphism characteristics. Note that the β1 subunit coded by PSMB6 contains a SNP that is close to fixation in humans, with derived allele frequency (DAF) = 0.98. (*B*) Representation of bovine 20S core complex, with nsSNP containing chains shown in orange. (*C*) Box plot showing the percentage of number of nonsynonymous mutations per nonsynonymous site among proteasome genes compared with all genes with at least one mutation (*n* = 17,294) in the Complete Genomics data set. We assign zero to any gene where only synonymous SNPs are detected (*n* = 2,191). Note that among 33 proteasome genes, 15 contain only sSNPs but no nsSNP. Outliers are not shown. \*\*\**P* \< 0.001.

Because high frequency coding polymorphism among a conserved gene set is unexpected, we asked whether the proteasome SNPs, or their high allele frequencies, may be caused by artifacts relating to the computational processing of the data. To do this, we first compared the frequencies of the 12 common (\>5% nsMAF) proteasome SNPs identified in the Complete Genomics data set, with nsMAF calculated from the phase I version of the 1000 genomes data set ([@mst098-B1]) ([supplementary material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). This revealed high consistency between data sets in comparisons with 14 populations (0.38 \< *ρ* \< 0.95, *P* \< 0.05 in 11 comparisons) ([supplementary fig. S5](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). However, because the samples included in the two data sets overlap, we used a second, independent exome sequencing data set of 200 Danish individuals ([@mst098-B29]) ([supplementary material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). Importantly, this data set is derived from primary tissue instead of cell lines, which also allows us the potential to exclude in vitro proteasome mutations. Ten proteasome nsSNPs from the Complete Genomics data set were detected in the Danish data set. All 10 had MAF \> 0.05 in both data sets and the allele frequencies across the SNPs were highly correlated (*ρ* = 0.71, *P* \< 0.02) ([supplementary fig. S6*A*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). We then asked whether high allele frequencies may be influenced by copy number variation. Using sequencing depth in the Danish data set as proxy for copy number, we found no indication that proteasome sites had higher sequencing depth than other sites ([supplementary fig. S6*B*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) and [*C*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). Known paralogs are not likely to cause the signal, as human proteasome genes have no close paralogs, and proteasome genes with and without distant paralogs showed no difference in nsMAF ([supplementary fig. S6*D*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). Also, we find no indication for higher synonymous polymorphism among proteasome genes ([supplementary fig. S7](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). Furthermore, we used a stringent cutoff for Hardy--Weinberg equilibrium testing to filter out SNPs with an excess of heterozygotes that could also be caused by paralogs ([supplementary material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). In conclusion, the pattern of high frequency nonsynonymous polymorphisms in human proteasome genes is replicable between data sets and is unlikely to be artifactual.

We then considered the possibility that the identified high frequency proteasome nsSNPs may be affecting the least functional parts of the respective proteins. We thus tested whether sites with common proteasome nsSNPs (MAF \> 0.05) show conservation across mammals. Six proteasome nsSNPs could be aligned to 13 high-quality mammalian genomes, and we found no substitutions among these species at these sites ([supplementary material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). In contrast, in 39% of common nsSNPs in other genes we find at least one substitution (one-sided binomial test *P* = 0.051). These results imply that some of the proteasome subunit sites bearing common nonsynonymous polymorphism in humans are not evolving neutrally in other mammals, and may have functional effects.

We then examined the potential functional role of common proteasome nsSNP alleles. With respect to physiological function, no genome-wide disease association has been reported for the common proteasome SNPs. With respect to protein structure, PolyPhen (v2) ([@mst098-B2]) predicted one of the 12 common mutations as "possibly-damaging," and SIFT ([@mst098-B26]) predicted two as "deleterious" ([supplementary table S3](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online). These were in the *PSMB3* and *PSMB4* genes, encoding subunits of the 20S proteasome core complex ([fig. 3](#mst098-F3){ref-type="fig"}*A*). The *PSMB4* mutation is within putative conserved domains according to BLASTP, and the *PSMB3* mutation is within an active site of the protein. Taken together with the conservation tendency across mammals, this information suggests that some proteasome gene-related SNPs in humans may affect functional sites.

Intriguingly, only about one-half of proteasome genes as annotated in KEGG (*n* = 18) carry nsSNPs in the Complete Genomics data set; the others (*n* = 15) only contain synonymous SNPs. This is significantly higher than the genome average (expected = 13%, observed = 45%, hypergeometric test *P* \< 0.001). Likewise, the median density of nonsynonymous mutations per nonsynonymous site is five times lower among proteasome genes than the genome average (Wilcoxon rank sum test *P* \< 0.001) ([fig. 3](#mst098-F3){ref-type="fig"}*C*). Surveying the distribution of the peptides coded by nsSNP-bearing genes within the proteasome complex, we further noticed a peculiar pattern: within the 20S catalytic core, only beta subunits carried human nsSNPs, with four genes with common nsSNPs ([fig. 3](#mst098-F3){ref-type="fig"}*A* and *B*). Yet another beta subunit, *PSMB6*, also carries a high frequency (\>95%) derived nsSNP. In contrast, the seven alpha subunits only contained sSNPs. Thus, the human proteasome, as a whole, appears under negative selection, despite common nsSNPs in one layer of its catalytic core.

What could allow nonsynonymous mutations in the core human proteasome to reach such high frequencies? A number of scenarios are conceivable: balancing selection specific to humans, ongoing positive selection, compensatory mutations following a fixation event in humans, or relaxed constraints. Given the multiple roles of this complex, including immune response, stress response, and aging ([@mst098-B7]; reviewed in [@mst098-B8]; [@mst098-B46]), positive or balancing selection on proteasome genes, due to human-specific changes in longevity or immune response is not implausible. To identify any signature of past or ongoing selection, we first surveyed human-chimpanzee differences in core proteasome genes. Aligning human, chimpanzee, and rhesus macaque beta subunit protein sequences revealed no human-specific substitution, only two high-frequency derived SNPs. Thus, these genes do not show evidence for adaptive change in their coding sequences in the human lineage. Proteasome genes also showed no indication of recent positive selection in European--American or in Yoruban individuals ([supplementary fig. S8](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online), either as high haplotype homozygosity measured by iHS ([@mst098-B49]), or as extremely low or high Tajima's *D* values indicating an excess of rare alleles or an excess of intermediate alleles, respectively ([@mst098-B45]). Neither did proteasome genes have high scores in a recently developed composite likelihood-based statistic for balancing selection (DeGiorgio M, Lohmueller KE, Nielsen R, in review). In fact, while proteasome genes had negative Tajima's *D* values consistent with negative selection and/or human population growth, those proteasome subunits carrying common nsSNPs tended to have Tajima's *D* values closer to zero than other proteasome genes, implying weaker negative selection. Notably, common nsMAF (\>5%) SNPs do not show conspicuous differentiation between African and non-African populations ([fig. 1](#mst098-F1){ref-type="fig"}*D*). We also find four common proteasome nsSNPs in the Denisovan genome ([@mst098-B31]) ([supplementary table S3](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) online), which suggests that a possible shift in selection pressure appeared at least 800,000 years ago. Finally, using a primate gene expression data set including different tissues ([@mst098-B4]), we found no consistent differentiation in gene expression between humans and chimpanzees among nsSNP containing proteasome genes (data not shown).

To summarize, our genome-wide scan for human-specific relaxation of constraint identified two candidate functions: olfactory transduction and proteasomal degradation. The former is well-studied, but the latter is novel and unexpected. Our results do not imply an overall relaxation of constraint among proteasome subunits; rather, common nonsynonymous SNPs appear clustered in the complex, and include sites under constraint in other mammals. The trend appears specific to the hominin lineage. Still, given the small sample size of the chimpanzee data set used here, nonsynonymous polymorphism in proteasome genes require further investigation among great apes.

The reason for high frequency nonsynonymous polymorphism in human proteasome genes remains unclear. We find no indication for positive or balancing selection on the genes in question. One possibility is that a general trend of relaxation of constraint in humans ([@mst098-B53]; [@mst098-B35]; [@mst098-B32]; [@mst098-B24]) affected these previously conserved sites by chance, although the significant GO classification makes this explanation unlikely. Alternatively, one may speculate that changes in human evolution that affected functions regulated by the proteasome--ubiquitin pathway, such as increased longevity ([@mst098-B28]), or increased intake of dietary protein ([@mst098-B15]; [@mst098-B3]), may have altered selective pressure on particular proteasome subunits. For example, the ubiquitin--proteasome system is a major contributor of protein turnover in muscle, which is directly affected by essential amino acid intake ([@mst098-B47]; [@mst098-B50]; [@mst098-B9]). All known human diets are more protein rich than that of chimpanzees ([@mst098-B15]). It is thus conceivable that increased consumption of essential amino acids reduced selection pressure on the human proteasome's efficacy for maintaining protein turnover, allowing for slightly deleterious mutations at previously conserved sites. More studies of the functional effects of common proteasome mutations humans may help to clarify this enigmatic point in the future.
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[Supplementary figures S1--S8](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) and [tables S1--S3](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/mst098/-/DC1) are available at *Molecular Biology and Evolution* online (<http://www.mbe.oxfordjournals.org/>).
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